期刊
DERMATOLOGY AND THERAPY
卷 9, 期 1, 页码 5-18出版社
ADIS INT LTD
DOI: 10.1007/s13555-018-0279-5
关键词
Body surface area; Clearance; Comorbidities; DLQI; Itch; PASI; Physician Global Assessment; Psoriasis
类别
资金
- Celgene
- Novartis
- Eli Lilly
- AbbVie
Engaging global key opinion leaders, the International Psoriasis Council (IPC) held a day-long roundtable discussion with the primary purpose to discuss the treatment goals of psoriasis patients and worldwide barriers to optimal care. Setting clear expectations might ultimately encourage undertreated psoriasis patients to seek care in an era in which great gains in therapeutic efficacy have been achieved. Here, we discuss the option for early treatment of all categories of psoriasis to alleviate disease impact while emphasizing the need for more focused attention for psoriasis patients with mild and moderate forms of this autoimmune disease. In addition, we encourage policy changes to keep pace with the innovative therapies and clinical science and highlight the demand for greater understanding of treatment barriers in resource-poor countries.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据